HUP9901077A2 - Oral tolerance in skin diseases presenting with t-cell mediated inflammation - Google Patents

Oral tolerance in skin diseases presenting with t-cell mediated inflammation

Info

Publication number
HUP9901077A2
HUP9901077A2 HU9901077A HUP9901077A HUP9901077A2 HU P9901077 A2 HUP9901077 A2 HU P9901077A2 HU 9901077 A HU9901077 A HU 9901077A HU P9901077 A HUP9901077 A HU P9901077A HU P9901077 A2 HUP9901077 A2 HU P9901077A2
Authority
HU
Hungary
Prior art keywords
skin diseases
cell mediated
oral tolerance
mediated inflammation
diseases presenting
Prior art date
Application number
HU9901077A
Other languages
Hungarian (hu)
Inventor
Youhai Chen
Thomas S. Kupper
Howard L. Weiner
Original Assignee
Autoimmune, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autoimmune, Inc. filed Critical Autoimmune, Inc.
Publication of HUP9901077A2 publication Critical patent/HUP9901077A2/en
Publication of HUP9901077A3 publication Critical patent/HUP9901077A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A találmány T-sejt által közvetített vagy T-sejttől függő gyűlladássaljáró bőrbetegség kezelésére alkalmas eljárásőkra és készítményekrevőnatkőzik. A találmány tárgyát ilyen betegségeknek bőrrel társűltbystander antigén őrális adagőlásával történő kezelésére alkalmaseljárásők és készítmények képezik. ŕThe invention relates to methods and compositions suitable for the treatment of inflammatory skin disease mediated by T-cells or T-cell-dependent. The subject of the invention are methods and compositions suitable for the treatment of such diseases by oral administration of skin-associated bystander antigen. ŕ

HU9901077A 1995-06-07 1996-06-05 Oral tolerance in skin diseases presenting with t-cell mediated inflammation HUP9901077A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48619095A 1995-06-07 1995-06-07

Publications (2)

Publication Number Publication Date
HUP9901077A2 true HUP9901077A2 (en) 1999-07-28
HUP9901077A3 HUP9901077A3 (en) 1999-11-29

Family

ID=23930947

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901077A HUP9901077A3 (en) 1995-06-07 1996-06-05 Oral tolerance in skin diseases presenting with t-cell mediated inflammation

Country Status (10)

Country Link
EP (1) EP0871478A1 (en)
JP (1) JPH11507383A (en)
KR (1) KR19990022556A (en)
AU (1) AU6333796A (en)
BR (1) BR9609014A (en)
CA (1) CA2219457A1 (en)
HU (1) HUP9901077A3 (en)
IL (1) IL122502A0 (en)
NO (1) NO975554L (en)
WO (1) WO1996040232A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064066A1 (en) * 1998-06-09 1999-12-16 Shionogi & Co., Ltd. Immune tolerance-inducing agents containing hard keratin or keratin-like substance
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd Immunological and oral tolerance-inducing composition and use thereof for the prevention and/or for the treatment of atherosclerosis
KR102027451B1 (en) 2012-11-02 2019-10-02 (주)아모레퍼시픽 Micro RNA, and screening method using the micro RNA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen

Also Published As

Publication number Publication date
AU6333796A (en) 1996-12-30
HUP9901077A3 (en) 1999-11-29
NO975554D0 (en) 1997-12-02
WO1996040232A1 (en) 1996-12-19
EP0871478A1 (en) 1998-10-21
KR19990022556A (en) 1999-03-25
JPH11507383A (en) 1999-06-29
CA2219457A1 (en) 1996-12-19
IL122502A0 (en) 1998-06-15
BR9609014A (en) 1999-12-14
NO975554L (en) 1997-12-02

Similar Documents

Publication Publication Date Title
NO981436D0 (en) Pharmaceutical angiostatic dipeptide compositions and their use
ES2177780T3 (en) MEDICATIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES USING INTERFERON TAU.
HUP0100627A1 (en) Prevention and treatment of amyloidogenic disease
UY26182A1 (en) PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
DE69929232D1 (en) VIRUSELY PARTICLES FOR INDUCING AUTOANTIC BODIES
KR930702026A (en) Treatment of autoimmune diseases by oral administration of autoantigens
ES2190784T3 (en) SUPPRESSION OF AUTOIMMUNE DISEASES BY SPECTING ANTIGENS.
TR200001977T2 (en) Compositions containing lipophilic glucocorticosteroid micelles
IT1224795B (en) USE OF ACETYL D-CARNITINE IN THE THERAPEUTIC TREATMENT OF GLAUCOMA AND PHARMACEUTICAL COMPOSITIONS USEFUL IN SUCH TREATMENT
DK0914144T3 (en) Therapeutic uses of BPI protein products for human meningococcemia
HUP0102479A2 (en) Basbo29 polynucleotides(s) and polypeptides from neisseria meningitidis
BR9809678A (en) Triptolyte derivatives useful in the treatment of autoimmune diseases
HUP9901077A2 (en) Oral tolerance in skin diseases presenting with t-cell mediated inflammation
NO980013L (en) Preparations and Methods for Treating T-Cell Mediated Diseases
WO1996020950A3 (en) Compositions and methods for treating rheumatoid arthritis
DK0862454T3 (en) CTLA-8 in combination with G-CSF or with G-CSF and IL-6 and use of CTLA-8 to treat infections
ATE310750T1 (en) VEROTOXIN B SUBUNIT FOR IMMUNIZATION
NO993921D0 (en) Medication for infertility and for increased fertility
DK0927031T3 (en) Pharmaceutical composition containing nimesulide for oral administration
Yaacob et al. Glossodynia and glossopyrosis: a discussion of the aetiology and management
MD1469G2 (en) Method of treatment of the burn shock
IT1277118B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC LIVER DISEASE
AU784159C (en) Method and compositions for administering taxanes orally to human patients
RU96122226A (en) METHOD OF VACCINATION AGAINST DIPHTERIA OF CHILDREN WITH SYSTEM CONNECTIVE TISSUE DISEASES
RU2001134578A (en) A method for the treatment of chronic intestinal diseases associated with dysbiosis